42 U.S.C. § 285f–3 — Sexually transmitted disease clinical research and training awards
submitted 82 years ago by Pub. L. 106-505 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 153 words · no verdicts yet
The Institute's Director may run a program moving new STD science into clinical care. The program funds promising clinicians at centers of excellence in STD research and treatment. Their work must happen where the disease's causes and progression are studied at a high level.
The Director* of the Institute is authorized to establish and maintain a program to enhance and promote the translation of new scientific knowledge into clinical practice related to the diagnosis, care and treatment* of individuals with sexually transmitted diseases.
In order to foster the application of the most current developments in the etiology, pathogenesis, diagnosis, prevention and treatment of sexually transmitted diseases, amounts made available under this section shall be directed to the support of promising clinicians through awards for research, study, and practice at centers of excellence in sexually transmitted disease research and treatment.
Research shall be carried out under awards made under subsection (b) in environments of demonstrated excellence in the etiology and pathogenesis of sexually transmitted diseases and shall foster innovation and integration of such disciplines or other environments determined suitable by the Director of the Institute.
Source credit: (July 1, 1944, ch. 373, title IV, § 447B, as added Pub. L. 106–505, title IX, § 901, Nov. 13, 2000, 114 Stat. 2349; amended Pub. L. 109–482, title I, § 103(b)(28), Jan. 15, 2007, 120 Stat. 3688.)
- 1944Enacted · Pub. L. 106-505 · 114 Stat. 2349
- 2007Amended · Pub. L. 109-482 · 120 Stat. 3688
A history note hasn’t been published yet. The record shows enactment by Pub. L. 106-505 on 1944-07-01.
all 0 arguments · sorted by: best
no arguments yet — make the first case